Is 9-OH (9-hydroxycorynantheidine) Legal in Oklahoma? (2026)

Instrument

Oklahoma Kratom Consumer Protection Act: kratom product definition; prohibited kratom products, label requirements, sale to minors, test results

Source

https://www.oscn.net/applications/oscn/DeliverDocument.asp?CiteID=489441

Retrieved

2026-11-08

Fingerprint

c3dfddc7805e516c

5. "Kratom product" means a food or dietary supplement that consists of or contains kratom leaf or kratom leaf extract that does not contain any synthesized kratom alkaloids, other synthesized kratom constituents, or synthesized metabolites of any kratom constituent in which the level of 7-hydroxymitragynine, on a percent weight basis, is not greater than one percent (1%) of the amount of total kratom alkaloids, as confirmed with a high-performance liquid chromatography testing method. For purposes of this paragraph, "synthesized" refers to substances produced using directed synthetic or biosynthetic chemistry, as opposed to traditional food preparation techniques such as heating or extracting;

A. A vendor shall not prepare, distribute, sell, or expose for sale any of the following:

1. A kratom product that does not meet the definition for a kratom product pursuant to 
Section 1-1432.2
of this title;

2. A kratom product that is contaminated with a dangerous nonkratom substance. A kratom product is contaminated with a dangerous nonkratom substance if the kratom product contains a substance that is not safe for human consumption;

3. A kratom product containing a level of 7-hydroxymitragynine in the alkaloid fraction that is greater than one percent (1%) of the alkaloid composition of the product;

4. A kratom product containing any synthesized alkaloid including synthesized mitragynine, synthesized 7-hydroxymitragynine or any other synthesized compounds of the kratom plant;

5. A kratom product containing any controlled substance listed in the Uniform Controlled Dangerous Substances Act, unless the product is compounded by a licensed pharmacist with the controlled substance dispensed in accordance with a valid prescription; or

6. A kratom product containing a level of any residual solvent that was used in the manufacturing of the extract that exceeds the residual level specified for pharmaceutical products in the document "Q3C - Tables and List, Guidance for Industry, [June 2017] ICH Revision 3" issued by the United States Department of Health and Human Services, Food and Drug Administration.

B. Kratom products shall be accompanied by a label bearing the following information prior to its sale in this state:

1. A list of the ingredients, which shall include the common or usual name of each ingredient used in the manufacture of the product, listed in descending order of predominance;

2. That the sale or transfer of kratom to a person under eighteen (18) years of age is prohibited;

3. The amount of total kratom alkaloids, mitragynine, and 7-hydroxymitragynine contained in the product;

4. The amount of total kratom alkaloids, mitragynine, and 7-hydroxymitragynine contained in packaging for the product;

5. The name and the principal street address of the vendor or the person responsible for distributing the product;

6. Any federal food allergen labeling requirements, if applicable, and clear and adequate directions for the consumption and safe and effective use of such product, including the recommended serving size, the number of servings in the container, and the number of servings that can be safely consumed in a day. Provided, liquid kratom products shall be packaged in a retail container that has clear serving size markings and be subject to the following requirements:

a. products of less than eight (8) fluid ounces which contain more than three servings shall be accompanied by a calibrated measuring device, and

b. if such a product contains more than the eight (8) fluid ounces, the requirements specified in subparagraph a of this paragraph do not apply;

7. Any precautionary statements as to the safety and effectiveness of the product, including a warning that a consumer should consult a health care professional on questions about the use of kratom and that the product may be habit-forming; and

8. A statement that states, "These statements have not been evaluated by the United States Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."

C. A vendor may not distribute, sell, or expose for sale a kratom product to an individual under eighteen (18) years of age.

D. Upon request by the State Department of Health, the vendor shall provide test results from a United States-based testing facility, that is an independent testing laboratory as defined in 
Section 1-1432.2
of this title, to confirm the items listed on the product label.

Instrument

Oklahoma Kratom Consumer Protection Act: prohibited kratom products, labeling, sale to minors, test results

Source

https://www.oscn.net/applications/oscn/DeliverDocument.asp?CiteID=489441

Retrieved

2026-10-29

Fingerprint

e8b5d67fa36b74b5

A. A vendor shall not prepare, distribute, sell, or expose for sale any of the following:

1. A kratom product that does not meet the definition for a kratom product pursuant to
Section 1-1432.2
 of this title;

2. A kratom product that is contaminated with a dangerous nonkratom substance. A kratom product is contaminated with a dangerous nonkratom substance if the kratom product contains a substance that is not safe for human consumption;

3. A kratom product containing a level of 7-hydroxymitragynine in the alkaloid fraction that is greater than one percent (1%) of the alkaloid composition of the product;

4. A kratom product containing any synthesized alkaloid including synthesized mitragynine, synthesized 7-hydroxymitragynine or any other synthesized compounds of the kratom plant;

5. A kratom product containing any controlled substance listed in the Uniform Controlled Dangerous Substances Act, unless the product is compounded by a licensed pharmacist with the controlled substance dispensed in accordance with a valid prescription; or

6. A kratom product containing a level of any residual solvent that was used in the manufacturing of the extract that exceeds the residual level specified for pharmaceutical products in the document "Q3C - Tables and List, Guidance for Industry, [June 2017] ICH Revision 3" issued by the United States Department of Health and Human Services, Food and Drug Administration.

B. Kratom products shall be accompanied by a label bearing the following information prior to its sale in this state:

1. A list of the ingredients, which shall include the common or usual name of each ingredient used in the manufacture of the product, listed in descending order of predominance;

2. That the sale or transfer of kratom to a person under eighteen (18) years of age is prohibited;

3. The amount of total kratom alkaloids, mitragynine, and 7-hydroxymitragynine contained in the product;

4. The amount of total kratom alkaloids, mitragynine, and 7-hydroxymitragynine contained in packaging for the product;

5. The name and the principal street address of the vendor or the person responsible for distributing the product;

6. Any federal food allergen labeling requirements, if applicable, and clear and adequate directions for the consumption and safe and effective use of such product, including the recommended serving size, the number of servings in the container, and the number of servings that can be safely consumed in a day. Provided, liquid kratom products shall be packaged in a retail container that has clear serving size markings and be subject to the following requirements:

a. products of less than eight (8) fluid ounces which contain more than three servings shall be accompanied by a calibrated measuring device, and

b. if such a product contains more than the eight (8) fluid ounces, the requirements specified in subparagraph a of this paragraph do not apply;

7. Any precautionary statements as to the safety and effectiveness of the product, including a warning that a consumer should consult a health care professional on questions about the use of kratom and that the product may be habit-forming; and

8. A statement that states, "These statements have not been evaluated by the United States Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease."

C. A vendor may not distribute, sell, or expose for sale a kratom product to an individual under eighteen (18) years of age.

D. Upon request by the State Department of Health, the vendor shall provide test results from a United States-based testing facility, that is an independent testing laboratory as defined in
Section 1-1432.2
 of this title, to confirm the items listed on the product label.

Instrument

Uniform Controlled Dangerous Substances Act, definitions (control; controlled dangerous substance)

Source

https://www.oscn.net/applications/oscn/DeliverDocument.asp?CiteID=437011

Retrieved

2026-10-29

Fingerprint

8697da003a2ce54e

10. "Control" means to add, remove or change the placement of a drug, substance or immediate precursor under the Uniform Controlled Dangerous Substances Act;

11. “Controlled dangerous substance” means a drug, substance or immediate precursor in Schedules I through V of the Uniform Controlled Dangerous Substances Act or any drug, substance or immediate precursor listed either temporarily or permanently as a federally controlled substance. Any conflict between state and federal law with regard to the particular schedule in which a substance is listed shall be resolved in favor of state law;

Instrument

OK KCPA - 1% 7-OH cap, total-kratom-alkaloids (names speciociliatine), synthetic ban, age 18

Source

https://www.oklegislature.gov/cf_pdf/2025-26%20ENR/SB/SB891%20ENR.PDF

Retrieved

2026-07-07

Fingerprint

e3683eff33ae5b35

Sec. 1-1432.2 Definitions. ... 3. “Kratom leaf” means the leaf of the kratom plant, Mitragyna speciosa ... The total alkaloid content of kratom leaf material ... shall not exceed three and one-half percent (3.5%) ... 4. "Kratom leaf extract" ... shall contain mitragynine as the most abundant alkaloid ... at a level that is equal to or exceeds twice that of any other alkaloid present ... 5. "Kratom product" means a food or dietary supplement that consists of or contains kratom leaf or kratom leaf extract that does not contain any synthesized kratom alkaloids ... or synthesized metabolites ... in which the level of 7-hydroxymitragynine, on a percent weight basis, is not greater than one percent (1%) of the amount of total kratom alkaloids ... 6. "Total kratom alkaloids" means the sum of mitragynine, speciociliatine, speciogynine, paynantheine, and 7-hydroxymitragynine; and 7. "Vendor" ...
Sec. 1-1432.4 Prohibited products. A. A vendor shall not prepare, distribute, sell, or expose for sale: 1. A kratom product that does not meet the definition ...; 2. ... contaminated with a dangerous nonkratom substance ...; 3. A kratom product containing a level of 7-hydroxymitragynine in the alkaloid fraction that is greater than one percent (1%) of the alkaloid composition of the product; 4. A kratom product containing any synthesized alkaloid including synthesized mitragynine, synthesized 7-hydroxymitragynine or any other synthesized compounds of the kratom plant; 5. ... any controlled substance ... unless compounded by a licensed pharmacist ...; 6. ... residual solvent ... exceeding ICH Q3C ... B. [labeling incl. total kratom alkaloids, mitragynine, 7-OH amounts; under-18 prohibition]. C. A vendor may not distribute, sell, or expose for sale a kratom product to an individual under eighteen (18) years of age. D. ... test results on request.